News | August 23, 2021
USFDA grants full approval for Pfizer-BioNTech Covid-19 vaccine
The vaccine will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of Covid-19 disease
The vaccine will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of Covid-19 disease
The data suggest that a booster dose given within 6 to 12 months after the second dose may help maintain a high level of protection against COVID-19.
The company posted net profit of Rs.124.45 crores for the period ended June 30, 2020.
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
Adjusted PAT declined 18.8% YoY
Revenue from operations for the year ended March 31, 2021 is ?2,239 crore
The company has posted net profit of Rs.397.06 crores for the 9 months period ended December 31, 2020.
He most recently served as Chief Medical Officer of AstraZeneca and Alexion
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
Subscribe To Our Newsletter & Stay Updated
